TNF-α blockade in chronic granulomatous disease–induced hyperinflammation: Patient analysis and murine model
- 30 September 2011
- journal article
- research article
- Published by Elsevier BV in Journal of Allergy and Clinical Immunology
- Vol. 128 (3), 675-677.e4
- https://doi.org/10.1016/j.jaci.2011.04.028
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Complications of Tumor Necrosis Factor–α Blockade in Chronic Granulomatous Disease–Related ColitisClinical Infectious Diseases, 2010
- The universe of immune deficiencies in Crohn's disease: a new viewpoint for an old disease?Scandinavian Journal of Gastroenterology, 2010
- A new genetic subgroup of chronic granulomatous disease with autosomal recessive mutations in p40phox and selective defects in neutrophil NADPH oxidase activityBlood, 2009
- Unrelated donor and HLA‐identical sibling haematopoietic stem cell transplantation cure chronic granulomatous disease with good long‐term outcome and growthBritish Journal of Haematology, 2009
- Chronic granulomatous disease as a risk factor for autoimmune diseaseJournal of Allergy and Clinical Immunology, 2008
- Branched fungal β‐glucan causes hyperinflammation and necrosis in phagocyte NADPH oxidase‐deficient miceThe Journal of Pathology, 2007
- Use of GM-CSF in the treatment of colitis associated with chronic granulomatous diseaseJournal of Allergy and Clinical Immunology, 2005
- Chronic granulomatous disease caused by a deficiency in p47phox mimicking Crohn’s diseaseClinical Gastroenterology and Hepatology, 2004
- Hyperresponsiveness of neutrophils from gp 91phox deficient patients to lipopolysaccharide and serum amyloid AImmunology Letters, 2004
- Deficiency of NADPH Oxidase Components p47phox and gp91phox Caused Granulomatous Synovitis and Increased Connective Tissue Destruction in Experimental Arthritis ModelsThe American Journal of Pathology, 2003